BioNTech signs MoU with UK govt to start clinical trials for mRNA cancer vaccine
BioNTech signs MoU with the British government to start mRNA cancer trials
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
BioNTech signs MoU with the British government to start mRNA cancer trials
Aurobindo Pharma announced that its fully-owned subsidiary, Eugia Pharma Specialities, received final approval from FDA to make and market Azacitidine injection for cancer.
Israeli researchers have succeeded in making computers into pathological assistants at a time when healthcare companies are trying to overcome a global shortage.
AstraZeneca, an Anglo-Swedish pharmaceutical company, is set to acquire Neogene Therapeutics, a biotechnology firm, for $320 million
Some vitamins can have fatal side-effects as a new study finds that Niacin may carry risk of brain cancer
About 45% of the world’s population, or 3.5 billion people, are suffering from oral diseases, a new study states.
The European Medicines Agency has suggested steps to minimize the risk of severe side effects associated with Janus kinase (JAK) inhibitors, used to.
HQ Team October 26, 2022: Aurobindo Pharma US has initiated a voluntary recall of two lots of tablets in the American market due to the.
HQ Team October 21, 2022: Canada has recalled more than a million units of dry shampoo products of London-based Unilever after detecting a.